$2.29 +0.05 (2.13%)

AYTU BioPharma, Inc. Common Stock (AYTU)

AYTU BioPharma, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of therapies for rare and specialty conditions. The company markets oral formulations of testosterone and other hormone-based treatments, aiming to address hormonal deficiencies and related health issues. Founded with a focus on innovation in hormone therapy, AYTU aims to expand its product offerings and pipeline to serve underserved patient populations.

🚫 AYTU BioPharma, Inc. Common Stock does not pay dividends

Company News

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire
GlobeNewswire Inc. • N/A • July 17, 2024

The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga • Lisa Levin • November 15, 2023

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an adjusted loss of $1.36 per share, versus market expectations for a loss of 95 cents per share. The company’s quarterly sales came in at $8.37 million versus estimates of $8.75 million. Shapeways shares fel...

Best Penny Stocks? 4 Hot Stocks With News This Week
PennyStocks • J. Samuel • September 28, 2023

Best penny stocks to buy? 4 with news to watch this week The post Best Penny Stocks? 4 Hot Stocks With News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

ANI Pharmaceuticals (ANIP) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research • Zacks Equity Research • May 8, 2023

ANI (ANIP) delivered earnings and revenue surprises of 244.12% and 28.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?